Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00126815

Enrollment

1000

Registered

2005-08-05

Start date

2004-02-29

Completion date

2008-04-30

Last updated

2016-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

prostate cancer, prostate specific antigen, radiotherapy, mathematical modeling

Brief summary

Clinical data are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.

Detailed description

Clinical data (prostate-specific antigen \[PSA\] response after radiotherapy) are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

MALE

Healthy volunteers

Inclusion criteria

* Prostate cancer treated with radiotherapy +/- hormones

Exclusion criteria

* Prostatectomy

Countries

Canada

Outcome results